| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/08/1996 | WO1996003495A1 Bradykinin b2 receptor modified transgenic non-human animals |
| 02/08/1996 | WO1996003438A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | WO1996003437A1 PTH OR PTHrP ANTAGONISTS |
| 02/08/1996 | WO1996003436A2 EQUINE η-INTERFERON |
| 02/08/1996 | WO1996003435A2 FELINE η-INTERFERON |
| 02/08/1996 | WO1996003434A1 Megakaryocyte differentiation/proliferation factor |
| 02/08/1996 | WO1996003433A1 New process for the production of biologically active protein |
| 02/08/1996 | WO1996003432A1 Novel process for the production of biologically active dimeric protein |
| 02/08/1996 | WO1996003431A1 Improvements relating to cell growth |
| 02/08/1996 | WO1996003429A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 02/08/1996 | WO1996003426A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 02/08/1996 | WO1996003425A1 Process for folding of proteins like recombinant hirudin or epidermal growth factor |
| 02/08/1996 | WO1996003423A1 Hapten-marked peptides |
| 02/08/1996 | WO1996003416A1 Nucleic acids encoding receptors for bombesin-like peptides |
| 02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
| 02/08/1996 | WO1996003410A1 Hydrophilic metal complexes |
| 02/08/1996 | WO1996003409A1 Metal complexes with charged linker |
| 02/08/1996 | WO1996003151A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | WO1996003148A1 Method and drug for treating diabetes |
| 02/08/1996 | WO1996003145A1 Influenza virus subunit conjugates |
| 02/08/1996 | WO1996003141A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | WO1996003140A1 HLA binding peptides and their uses |
| 02/08/1996 | WO1996003138A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 02/08/1996 | WO1996003136A1 Inhibition of platelet binding |
| 02/08/1996 | WO1996003122A2 Use of gabapentin in the treatment of anxiety and panic |
| 02/08/1996 | WO1996003116A1 Controlled release of metal cation-stabilized interferon |
| 02/08/1996 | WO1996003106A2 Allergenic peptides derived from poa pratensis |
| 02/08/1996 | WO1996003051A1 Production of collagen in the milk of transgenic mammals |
| 02/08/1996 | WO1996003043A1 Human brain specific kinase |
| 02/08/1996 | WO1995026983A3 Treatment or diagnosis of abnormal signal transduction disorders |
| 02/08/1996 | WO1995022611A3 Methods and compositions for stimulating bone cells |
| 02/08/1996 | DE4427531A1 Human beta-defensin 1 isolated from haemofiltrate |
| 02/08/1996 | DE4427395A1 New human circulating cytokine CC-1 and related nucleic acid |
| 02/08/1996 | DE4427221A1 Retrovirus-induzierte Osteoklasten-Modulation für die Osteoporose-Therapie Retrovirus-induced osteoclast modulation for osteoporosis therapy |
| 02/08/1996 | DE4418936A1 Polypeptid Polypeptide |
| 02/08/1996 | DE4192335C2 New T-cell epitope(s) derived from the TraT protein of E.Coli |
| 02/08/1996 | CA2196052A1 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 02/08/1996 | CA2196051A1 Surface expression of enzyme in gene directed prodrug therapy |
| 02/08/1996 | CA2196044A1 Insect viruses, sequences, insecticidal compositions and methods of use |
| 02/08/1996 | CA2195994A1 Controlled release of metal cation-stabilized interferon |
| 02/08/1996 | CA2195868A1 Antibodies which activate an erythropoietin receptor |
| 02/08/1996 | CA2195800A1 Receptor-ligand assay |
| 02/08/1996 | CA2195678A1 Bradykinin b2 receptor modified transgenic non-human animals |
| 02/08/1996 | CA2195671A1 Hla binding peptides and their uses |
| 02/08/1996 | CA2195669A1 Picornavirus l proteinase and methods of making and using thereof |
| 02/08/1996 | CA2195665A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 02/08/1996 | CA2195648A1 Metal chelate-labelled peptides |
| 02/08/1996 | CA2195630A1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 02/08/1996 | CA2195629A1 Src sh3 binding peptides and methods of isolating and using same |
| 02/08/1996 | CA2195539A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |
| 02/08/1996 | CA2195525A1 Stable analogs of bioactive peptides containing disulfide linkages |
| 02/08/1996 | CA2195404A1 Diagnostic method and probe |
| 02/08/1996 | CA2195099A1 A polynucleotide herpes virus vaccine |
| 02/08/1996 | CA2194578A1 New process for the production of biologically active protein |
| 02/08/1996 | CA2194465A1 Process for preparing viruses and viral vectors |
| 02/08/1996 | CA2194183A1 Influenza virus subunit conjugates |
| 02/08/1996 | CA2194177A1 Process for folding of proteins like recombinant hirudin or epidermal growth factor |
| 02/08/1996 | CA2192787A1 Pth or pthrp antagonists |
| 02/07/1996 | EP0695803A2 Epitopic regions of pneumococcal surface protein A |
| 02/07/1996 | EP0695802A2 Human CRH receptor-related receptor |
| 02/07/1996 | EP0695801A2 Yeast protein derived peptide compositions, a process for preparing them and their use |
| 02/07/1996 | EP0695760A1 Novel tumor marker for lung cancer |
| 02/07/1996 | EP0695750A1 Naphthyridinium derivative, method for its production; antibody against said derivative and the use of said antibody |
| 02/07/1996 | EP0695361A1 Expression of heterologous genes according to a targeted expression profile |
| 02/07/1996 | EP0695360A1 Defective recombinant adenoviruses for gene therapy of tumours |
| 02/07/1996 | EP0695358A1 Recombinant antigens from mumps virus and their use in vaccines |
| 02/07/1996 | EP0695357A1 Mammal cell lines and method of obtaining glycoproteins |
| 02/07/1996 | EP0695356A1 Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii |
| 02/07/1996 | EP0695355A1 Protein having tpo activity |
| 02/07/1996 | EP0695352A1 Dna encoding cobra c3, cvf1, and cvf2 |
| 02/07/1996 | EP0695351A1 Isolation, selection and propagation of animal transgenic stem cells |
| 02/07/1996 | EP0695347A1 Methods and materials for treatment of individuals infected with intracellular infectious agents |
| 02/07/1996 | EP0695311A1 Cellulose binding domain |
| 02/07/1996 | EP0695310A1 A method of detecting the presence of and converting of a polypeptide |
| 02/07/1996 | EP0695307A1 Modified protein and peptide pharmaceuticals |
| 02/07/1996 | EP0695191A1 35/31 kDa SUBUNIT OF THE $i(ENTAMOEBA HISTOLYTICA) ADHERENCE LECTIN |
| 02/07/1996 | EP0695190A1 Regulator regions of g proteins |
| 02/07/1996 | EP0695189A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 02/07/1996 | EP0695188A1 Novel bowman-birk inhibitor product for use as an anticarcinogenesis agent |
| 02/07/1996 | EP0671930A4 Prophylaxis and treatment of adverse oral conditions with biologically active peptides. |
| 02/07/1996 | EP0666921A4 Monocot having dicot wound inducible promoter. |
| 02/07/1996 | EP0563132B1 Tetrapeptide derivatives and analogues |
| 02/07/1996 | EP0519953B1 Acyl phosphate esters and modification of proteins therewith |
| 02/07/1996 | EP0420848B1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 02/07/1996 | CN1116427A Polypeptide and anti-hiv agent prepared therefrom |
| 02/07/1996 | CN1030922C Process for preparation of new amino acid derivatives |
| 02/06/1996 | US5489743 Transgenic animal models for thrombocytopenia |
| 02/06/1996 | US5489742 Rat genome containing hla-b27 or dr4 genes |
| 02/06/1996 | US5489676 Polypeptides that potentiate bactericidal/permeability-increasing protein and methods for treating bacterial infections |
| 02/06/1996 | US5489575 Polypeptides and their use |
| 02/06/1996 | US5489533 Human intercellular adhesion molecule-2; antiinflammatory agents |
| 02/06/1996 | US5489528 Recombinant core-streptavidin |
| 02/06/1996 | US5489527 Translation of m-RNA |
| 02/06/1996 | US5489520 Process of producing fertile transgenic zea mays plants and progeny comprising a gene encoding phosphinothricin acetyl transferase |
| 02/06/1996 | US5489519 Multidrug resistance protein |
| 02/06/1996 | US5489517 Gramnegative bacteria are caused to express a gene consisting of outer membrane protein lamb, ompf signal sequence joined to a dna sequence encoding insulin-like growth factor-1 and a transcription termination sequence, recovering mature one |
| 02/06/1996 | US5489514 DNA coding for growth-inhibitory factor and use thereof |
| 02/06/1996 | US5489511 Dna probe which hybridizes with dna sequences in borrelia |
| 02/06/1996 | US5489432 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 02/06/1996 | US5489430 Poultry mycoplasma antigen, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same |